LumiraDx Ltd (OTCPK:LMDXF)
$ 0.01 0.009 (900%) Market Cap: 3.19 Mil Enterprise Value: 380.61 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

LumiraDx Ltd at Raymond James Institutional Investors Conference Transcript

Mar 07, 2023 / 09:35PM GMT
Release Date Price: $1.04 (-3.70%)
Andrew Cooper
Raymond James - Analyst

Great. Welcome to one of the final Tuesday presentations of the Raymond James Institutional Investor Conference. I'm happy to be joined by Dorian LeBlanc from LumiraDx. Exciting opportunity and exciting platform here, I think, in point of care diagnostics. Really trying to change what's out there.

And with that, I will pass it over to Dorian for a presentation. Thanks, Dorian.

Dorian LeBlanc
LumiraDx Limited - CFO & VP, Global Operations

Great, Andrew. Thank you very much, and appreciate Raymond James giving us the opportunity to present here today and appreciate you all taking the time to learn more about the LumiraDx story. So for those of you who may not be as familiar with the company, this is our founders, forward start-up and point-of-care diagnostics. So Ron Zwanziger, Dave Scott, Jerry McAleer. Real pioneers in point-of-care diagnostics.

The first two companies in blood glucose. They launched the first electrochemical blood glucose analyzer that could be used by a patient at home. That

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot